跳至主要内容
临床试验/NL-OMON22751
NL-OMON22751Other不适用

Contrast kinetics of Gadobutrol in dynamic contrast-enhanced MRI of the breast in patients with histologically proven breast cancers initially classified as BIRADS 5 with and without a computer aided detection system.

Atrium Medisch Centrum Parkstad0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
Other
发起方
入组人数
30

研究概览

简要总结

暂无简介。

入排标准

入选标准

  • At least 18 years of age
  • Histologically proven breast cancer (BIRADS 5)
  • Patients who are willing to undergo study procedures

排除标准

  • Patients who have previously entered this study
  • Patients who are or are suspected in pragnancy or nursery
  • Patients with a contraindication for MRI
  • Patients who have received any contrast material within 48 hours prior to injection with study or comparator drug.
  • Patients who require emergency treatment
  • Patients with impaired renal function of CKD stadium 3 and higher (e.g. creatinine clearance < 60ml/ min). In patients with known renal impairment, clearance will be calculated based on serum creatinine level using the Cockroft-Gault formula. Calculation of the clearance must be done before begin of study.
  • Patients with known anaphylactoid or anaphylactic reaction to any contrast media

研究者

发起方
Atrium Medisch Centrum Parkstad

相似试验

终止
不适用
Gadobutrol Versus Gadopentetate Dimeglumine or Gadobenate Dimeglumine Before DCE-MRI in Diagnosing Patients With Multiple Sclerosis, Grade II-IV Glioma, or Brain MetastasesAdult Anaplastic (Malignant) MeningiomaAdult Anaplastic AstrocytomaAdult Anaplastic EpendymomaAdult Anaplastic OligodendrogliomaAdult Brain Stem GliomaAdult Choroid Plexus NeoplasmAdult Diffuse AstrocytomaAdult EpendymoblastomaAdult EpendymomaAdult Giant Cell GlioblastomaAdult GlioblastomaAdult GliosarcomaAdult Grade II MeningiomaAdult MedulloblastomaAdult Mixed GliomaAdult OligodendrogliomaAdult Papillary MeningiomaAdult Pineal Gland AstrocytomaAdult PineoblastomaAdult Primary Melanocytic Lesion of MeningesAdult Supratentorial Primitive Neuroectodermal TumorMalignant Adult Intracranial HemangiopericytomaMetastatic Malignant Neoplasm in the BrainRecurrent Adult Brain NeoplasmMultiple Sclerosis
NCT02967380University of Southern California14
已完成
不适用
Effects of Gadobutrol on background parenchymal enhancement in breast dynamic MRIPatients who are scheduled to undergo breast dynamic MRI for breast cancer or suspected breast cancer
JPRN-UMIN000026386Sagara hospital120
终止
不适用
Comparison of Contrast Agents for MRI Perfusion Analysis in Brain Tumor PatientsCentral Nervous System Neoplasms
NCT02095353University of Nebraska6
进行中(未招募)
不适用
Comparison of two Gadolinium containing MR contrast media in patients with symptoms of cerebrovascular diseasePatients with high grade carotid artery stenosis or acute cerebral ischemia
EUCTR2012-001582-33-DEniversity Hospital Erlangen
已完成
4 期
Intraindividual cross-over comparison of Gadobutroland Gadoterate enhanced combined DSC-MR-Perfusion and MRAngiographyin patients with cerebrovascular diseaseSubjects with acute stroke and/or subjects harboring an intracranial stenosis or extracranial ICA stenosisI67Other cerebrovascular diseases
DRKS00009914niversitätsklinikum Erlangen73